Clinical Trials Browser

Phase 1/2 × Neoplasms × apatinib × Clear all

NCT04133337 2019-10-21

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT01497704 2017-10-02

Dose-Escalation and Safety Trial of YN968D1

Phase 1/2 Completed

Neoplasms